Chronic back pain Musculoskeletal Diseases Dorsalgia
Conditions
Interventions
The purpose of this randomised controlled trial is to examine the effectiveness of combinations of graded activity exercise (GA) with individual cognitive behavioural therapy (CBT) in subgroups of pat
Sponsors
Zurzach Rehabilitation Foundation SPA (Switzerland)
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1. Stationary patients of RehaClinic of at least 18 years old, either sex 2. Diagnosis of chronic back pain: at least 3 months of continuous back pain localised in the lumbar, thoracic, and/or cervical region 3. Willingness to learn behavioural patterns and motivation to participate in graded activity exercise programs 4. Ability to formulate realistic functional goals 5. Sufficient cognitive abilities and German language skills to understand the content of the interventions 6. Agreement to participate in the program and the assessment by written, signed informed consent
Exclusion criteria
Exclusion criteria: 1. Severe somatic illness requiring specific treatment such as cancer, inflammatory rheumatic disease, neurological disease, pain after a recent operation (less than 6 months) 2. Specific back pain, defined as herniated disc, ankylosing spondylitis, spondylolisthesis, spinal fracture, or other relevant neurological diseases 3. Specific medical disorders and cardiovascular diseases, preventing participation at physical exercise 4. Pregnancy 5. Manifest psychiatric disorder such as dementia, psychosis, suicidality 6. Whiplash associated disorders
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Self-reported functional disability (Oswestry Disability Index), measured at T0, T2, T3 and T6. Timepoints: T0: 4 weeks before entry T1: entry to pain programme T2: discharge from pain programme T3: 3 months follow-up T6: one year follow-up | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Observed functional disability: the physical performance tests Back Performance Scale (BPS) and 5-Minute Walk Distance, measured at T1 and T2 2. Global perceived effect on daily functioning, measured at T2, T3 and T6 3. The Numeric Rating Scale (NRS) for pain, measured at T1, T2, T3 and T6 4. The subscales "Ability to decrease pain", and "Ability to control pain" of the Coping Strategies Questionnaire (CSQ), measured at T1, T2, T3 and T6 5. Mental health (Hospital Anxiety and Depression Scale [HADS]), measured at T1, T2, T3 and T6 6. Pain Catastrophising Scale (PCS), measured at T1, T2, T3 and T6 7. Treatment expectancy and credibility (Credibility/Expectancy Questionnaire [CEQ]), measured at T1 Timepoints: T0: 4 weeks before entry T1: entry to pain programme T2: discharge from pain programme T3: 3 months follow-up T6: one year follow-up | — |
Countries
Switzerland
Outcome results
None listed